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INTRODUCTION 
 
If I may begin on a personal note, it has taken me more 
than 30 years to understand why the evolutionary 
biology of aging is not adequately understood by the 
majority of gerontologists, to say nothing of the 
overwhelming majority of the non-biologists who are 
interested in the problem of aging.  It’s not that we 
evolutionists haven’t tried.   In my own case, I have 
repeatedly tried to convey the evolutionary approach to 
the gerontological community, in both books and 
articles, across a variety of levels and venues.  During 
the last three decades, I have developed some 
understanding of the great conceptual gulf between 
gerontology and evolutionary biology.  In the last few 
years, as the evolutionary biology of aging has been 
revolutionized by a deeper understanding of the 
Hamiltonian foundations of aging and late life [1], I 
have been particularly pessimistic about bridging this 
gulf, because the evolutionary theory and experimen-
tation in this area have become yet more abstruse, 
compared to the intuitively more digestible evolutionary 
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Abstract.  Aging  is  not  simply  an  accumulation  of  damage  or  inappropriate  higher‐order  signaling,  though  it  does
secondarily  involve  both  of  these  subsidiary  mechanisms.    Rather,  aging  occurs  because  of  the  extensive  absence  of
adaptive  genomic  information  required  for  survival  to, and  function at,  later adult ages, due  to  the declining  forces of
natural selection during adult  life.   This absence of  information  then secondarily  leads  to misallocations and damage at
every  level of biological organization.   But  the primary problem  is a  failure of adaptation at  later ages.   Contemporary
proposals concerning means by which human aging can be ended or cured which are based on simple signaling or damage
theories  will  thus  reliably  fail.    Strategies  based  on  reverse‐engineering  age‐extended  adaptation  using  experimental
evolution and genomics offer the prospect of systematically greater success. 
 
 
 
biology of aging that we had circa 1990 [2]. 
 
But I think I have now found a possible solution to this 
communication problem, a solution that might bridge 
the gulf between evolutionary biologists and the 
gerontological community.  This solution is the concern 
of the present article; ideally it will help resolve a “two 
cultures” problem that has afflicted, and indeed 
impaired, gerontology for more than a century.  In 
addition, as a secondary issue, I believe that the 
explanatory breakthrough that I offer here should help 
the gerontological community see the cogency of the 
intuitive disquiet that many of them feel about recent 
attempts to “end” or “cure” aging, such as the SENS 
proposal of de Grey [3].   I will begin by stating my 
central thesis baldly.  The rest of the article will then 
attempt to explain and unpack this thesis for those who 
aren’t evolutionary biologists.  
 
Species that have distinguishable adults enjoy early 
adult health because of adaptations built by natural 
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selection acting over entire genomes, adaptations that 
are the cumulative product of many millions of years of 
evolution building vast libraries of adaptive genomic 
information.  These adaptations are fine-tuned accor-
ding to the recent evolutionary histories of populations 
of these species, where this fine-tuning involves 
thousands of nucleotide base-pairs distributed across 
entire genomes with effects that are typically both 
pleiotropic and epistatic across component adaptive 
functions.  When forces of natural selection acting on 
the physiological processes that underlie adaptation 
progressively weaken at later adult ages, as they must in 
all organisms with ovigerous reproduction according to 
Hamiltonian theory [1,4], there is a reduction in the 
adaptive genomic information required for survival and 
reproduction at those ages.  This reduction in genomic 
information then leads to innumerable and pervasive 
failures of physiological tuning at later ages, including 
dysfunctional allocative signaling and cumulative cell 
damage, among many other types of adaptive failure.  
Since adaptation involves the careful tuning of 
functions at every level, from molecule to cell to tissue 
to organ to overall bodily integration, the failure of 
adaptation necessarily will take place at all of these 
levels as well.  This is what the absence of the required 
adaptive genomic information necessarily produces at 
later adult ages. 
 
Nonetheless, it is easy for evolution by natural selection 
to build the adaptive genomic information-base required 
to sustain healthspan radically.  There are no absolute 
physiological barriers to it doing so.  This is dramati-
cally revealed by the following:  (i) the non-aging 
species in which the forces of natural selection never 
fall; (ii) the non-aging germ lines of all species that are 
not undergoing evolutionary genomic meltdown; and 
(iii) the ease with which experimental evolution can 
slow aging when the forces of natural selection are 
manipulated in the laboratory.   More accurately, these 
statements are respectively better rendered as follows:  
(i) adaptation is maintained at all ages in species in 
which the forces of natural selection never fall; (ii) 
germ lines are indefinitely sustainable in species that are 
not undergoing evolutionary genomic meltdown; and 
(iii) the genomic information required for prolonged 
age-specific adaptation is easily produced by outbred 
laboratory populations in which the forces of natural 
selection are artificially sustained at high levels at later 
ages. 
 
I will now set about explaining these ideas step-by-step, 
in effect supplying a brief tutorial in adaptational 
genomics with particular relevance to the problem of 
aging. 
Adaptation and the Genome 
 
The chief way in which biologists first learn about the 
genetic basis of evolutionary change is with simple 
examples like the substitution of melanic alleles at 
pigmentation loci in the case of Lepidopteran industrial 
melanism.  I have used this pedagogical cliché in an 
evolution textbook myself [5].  This example makes it 
seem as if natural selection characteristically works by 
targeting a single gene, with evolution achieving a 
simple substitution of one allele for another.  Another 
classic textbook example of natural selection is the 
sickle-cell hemoglobin polymorphism, in which 
heterozygotes for the sickling and normal alleles have 
both resistance to malaria and reasonable erythrocyte 
structure, most of the time.  Again, this simple example 
suggests the action of natural selection to solve adaptive 
problems using alleles of large effect at a single locus. 
Unfortunately, these examples are wholly misleading.  
In most cases of a strong phenotypic response to 
selection, in either nature or the laboratory, there are a 
large number of loci involved.  It was precisely this 
problem that was at the root of many of Darwinism’s 
problems incorporating Mendelian genetics, before R.A. 
Fisher created quantitative genetics in 1918 [6].  
Quantitative genetics is the tool that evolutionary 
geneticists, and significantly plant and animal breeders 
as well, use to deal with the inheritance of “quantitative 
characters” or “complex traits.”  Conversely, when we 
have cases in which natural selection maintains genetic 
variation, as in the case of the alcohol dehydrogenase 
locus in Drosophila melanogaster, the selective 
mechanisms that underlie such polymorphism are often 
remarkably obscure.  That is, unlike the textbook cases 
of industrial melanism and sickle-cell anemia, the 
relationship between natural selection and the genome 
is characteristically “many-to-many,” with numerous 
loci and complex phenotypic effects of selection being 
the norm.  This is why the study of the genetic basis of 
evolutionary change is so difficult [7, 8].   
 
In a few cases, we can find simple connections between 
the genome and particular phenotypes, but these are not 
representative.  This should not be surprising.  Any 
allelic difference that can improve three or four 
characters will be favored by natural selection, possibly 
even if it has deleterious effects on one or two other 
characters that have less net impact on Darwinian 
fitness.  Alleles are selected on the basis of their 
average effects on the entire adaptive phenotype, as 
quantified by Darwinian fitness, over the range of 
genotypic backgrounds in which they occur. 
 
Even though we find it easier to imagine that a gene is 
“for” one attribute or another, evolution by natural 
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selection can exploit pleiotropic effects across multiple 
characters whenever they arise.  It isn’t constrained by 
our limited understanding, or any need to be elegant.  
Evolution is genomically complex.  It builds adaptations 
by accumulating information of great genomic and 
functional complexity over millions of years, indeed 
billions of years.  That is, adaptations reflect the long-
term accretion of useful genomic information, 
information that functionally manifests itself in the fine-
tuning of networks of interacting elements, both 
proteins and RNAs of widely varying sizes and roles.  
That is why superoxide dismutase proteins can be found 
in so many different organisms; superoxide dismutases 
are very useful enzymes in vast numbers of different 
species, in each of which they undergo further fine-
tuning in order to improve their operation in the 
particular physiological networks that underlie the 
survival and reproduction of members of that particular 
species. 
 
Aging:  What Happens When Adaptation Goes Away 
 
As Weismann and other evolutionary biologists have 
realized over the last century and more [9], when 
natural selection pays attention to survival to, and 
reproduction at, later ages it is trivial for evolution to 
build adaptations that will enable organisms to do both 
of these things.  Thus it is easy for evolutionary 
biologists to deliberately produce organisms with 
slowed or postponed aging, as our publications have 
shown since 1980 [1, 4].  All we have to do is extend 
the period during which the forces of natural selection 
act with full force.  Furthermore, it is clear that this 
entails genetic and functional changes involving many 
loci [10]. 
 
Conversely, what gerontology normally does is 
characterize the breakdown of age-specific adaptation, 
even though most gerontologists don’t think of 
themselves as evolutionary biologists.  Failing to take 
the adaptational genome-wide foundations of aging can 
lead to numerous problems of experimental design and 
interpretation.  For example, gerontologists may worry 
about whether or not they should be studying the 
maintenance of fertility and other adaptive functions, 
such as competitive ability, that are of no direct 
relevance to the survival of isolated individuals.  Is, for 
example, a sterile fruit fly or a castrated salmon that 
lives much longer actually an example of slowed aging?  
What about a dwarf mouse that can only be kept alive 
with a “companion nurse” mouse, to keep it warm?  Or 
a nematode that lives much longer in one laboratory 
protocol, but which has impaired survival or 
competitive function under other laboratory conditions 
[11]? 
These paradoxes arise because, in studying aging, 
gerontologists are studying the genome-wide 
breakdown of adaptation.  The study of adaptation over 
entire genomes is laden with both conceptual and 
experimental complexities.  I now give some typical 
examples of relevance to the study of aging.  These 
complexities illustrate the extent to which standard 
gerontological experiments are entangled with issues 
from evolutionary biology.   
 
(1) Inbreeding depression tends to degrade adaptation at 
every age.  This makes the study of heavily inbred 
laboratory animals particularly inappropriate for 
research on aging, because aging is a phenomenon 
which hinges on the loss of adaptation with adult age.  
Inbred animals will show impairments of adaptation at 
every age, obscuring the essential feature of aging as a 
period of progressively impaired adaptation that follows 
a period of adequate adaptation. 
 
(2) Genotype-by-environment interactions arise when 
organisms are assayed in different environments, 
particularly environments that are evolutionarily novel 
[12].  In the context of aging research, this can make 
genetic effects on longevity difficult to reproduce when 
protocols are changed [13].  More profoundly, studying 
the loss of adaptation in an organism that has not 
already adapted to the laboratory setting employed in an 
experiment will obscure what is going on in its aging, 
functionally, genetically, and physiologically. 
 
(3) The adaptive “costs of reproduction” underlie the 
well-known antagonistic pleiotropy mechanism for the 
evolution of aging [14].  The costs of reproduction can 
also supply a ready way to generate extended lifespan, 
simply by reducing fecundity [15].  Thus evolutionary 
biologists expect that experimental manipulations which 
attenuate reproduction will often increase longevity, but 
because this involves trading one adaptation for another, 
we do not regard the resulting demography as a case of 
slowed or postponed aging. 
 
(4) Significantly, these last two genetic mechanisms can 
interact, genotype-by-environment interaction making it 
difficult to detect genetic trade-offs, even when 
gerontologists are trying to find them [11]. This 
difficulty will be still greater when gerontologists are 
not particularly keen to find evidence for such trade-
offs. 
 
(5) “Longevity mutants” will characteristically suffer 
from adverse pleiotropic effects in at least some 
environments, because generally superior “longevity 
assurance” mutants will be favored in nature.  Vastly 
more mutations will have been generated in the 
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evolution of any species than we will ever produce in 
our laboratories in the comparatively short-term and 
small-scale mutation screens that we can perform.  
Generally beneficent alleles should have already been 
fixed in the course of evolution by natural selection, 
since they would be key adaptive substitutions. 
 
Aging is Not a Disease 
 
There are those who seek to have the NIH declare that 
aging is “a disease,” so that the FDA can review 
applications for pharmaceutical status of agents that 
claim to “cure this disease.”  There is no question that 
individuals who suffer from either juvenile or adult 
onset progerias, be they Hutchinson-Gilford’s progeria 
or Werner’s syndrome, are indeed suffering from 
diseases.  They have well-defined spectra of pathologies 
that are due to single genetic differences.  
Pharmaceuticals or somatic gene engineering 
interventions can usefully target such genetic diseases, 
and are worthy of FDA approval if they work well. 
 
What the rest of us have is a failure of natural selection 
to build the adaptations required for our continued 
survival and reproduction.  As such, while there is a 
well-defined underlying evolutionary cause, the 
spectrum of aging pathologies that we suffer are 
multifarious and the loci that are responsible for them 
are numerous and sometimes even diffuse in their 
responsibility, just like the loci that are responsible for 
most of our adaptations. 
 
Aging is not a well-defined disease.  If such an “aging 
disease” terminology were adopted, it would be just as 
reasonable to say that wolves suffer from the disease of 
lacking adaptations to survive in human habitats, unlike 
dogs, which do have such adaptations.  What then is the 
cure for the wolf disease? 
 
Nor is Aging Merely Cumulative Damage 
 
Part-whole confusions are commonplace targets of 
logical training.  Aging can result in cumulative damage 
without itself being nothing more than cumulative 
damage, unless the term “damage” is inappropriately 
broadened to mean anything that is involved in aging.  
This would lead to as many confusions as redefining the 
term “disease” to include aging. 
 
Yet the field of gerontology has assumed that some 
type(s) of inexorable damage or cumulative disruption 
is the entire source of aging, from its inception with 
Aristotle to the free-radical theory of aging to the 
recently developed rationale for SENS [3, 16].  This 
assumption began to unravel thanks to the work of 
Carey et al. [17] and Curtsinger et al. [18], which first 
showed the demographic cessation of aging.  These 
trailblazing publications set evolutionary biologists to 
work re-evaluating their interpretation of the functional 
impact of the plateaus in the forces of natural selection 
which follow their decline [19, 20].  How can the 
declines with age in survival probability and fecundity 
cease, if aging is due to cumulative damage?  They 
can’t.  But they can in straightforward evolutionary 
models [19, 21]. 
 
The conundrum of aging coming to a stop, and its 
resolution using evolutionary theory [19, 21] and 
experimental evolution [e.g. 22], reveals yet again how 
the foundations of gerontology actually lie within 
evolutionary biology.  Puzzles like whether or not aging 
can possibly come to an end late in life are readily 
resolved using the research tools of evolutionary 
biology, both theoretical and experimental.   
 
The Attempt to “End Aging” 
 
But things become still worse when we turn to 
proposals for “ending aging,” “curing the aging 
disease,” and other recent aspirational infirmities of the 
anti-aging movement.  As I will now argue, it is 
particularly when we turn to these hopes that it becomes 
obvious that gerontology needs evolutionary 
foundations and tools.  
 
Let us start with the advocates of hormone 
supplementation as a cure for “the aging disease.”  There 
is at least some bare evolutionary credibility behind such 
proposals, in that hormonal manipulations are heavily 
implicated in the beneficial responses to castration in 
both animal and plant species [23].  Hormones are indeed 
the master controls of life-history, and changing their 
levels demonstrably has pervasive functional effects [24].  
But the problem is that antagonistic pleiotropy is the 
likely mechanism behind the benefits that have been 
realized from hormonal manipulation.  Because repro-
duction is costly, limiting it hormonally should 
sometimes produce longevity benefits. 
 
Ironically, the most widely used hormone interventions 
in “anti-aging medicine” involve hormone supplemen-
tation with growth hormone or sex steroids, which 
experimental data and evolutionary theory both suggest 
will decrease lifespan and later-life somatic functions, 
thanks to increased physiological investment in costly 
functions related to reproduction.  This couldn’t be a 
more ill-founded therapeutic strategy, from the 
standpoint of evolutionary theory. 
 
Then we have those pharmaceutical strategies that are  
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based on emulating the pathways implicated in the 
response of lifespan to dietary restriction, particularly 
sirtuin-targeting agents like resveratrol [e.g. 25].  Again, 
like hormone manipulation, these pathways are heavily 
bound up with the regulation of reproduction, making 
the curtailment of the cost of reproduction the most 
likely mechanism by which the beneficial effects of 
emulating dietary restriction are achieved [cf. 26].  This 
is a strategy in which longevity is increased by 
metabolic refrigeration, pseudo-hibernation, or 
curtailing functions [11].  From the standpoint of 
evolutionary biology, this is, again, not an extension of 
the period of adaptation.  It is instead trading one set of 
adaptations off against another.  Most people do not 
regard curtailing their metabolism, cognition, affective 
stability or reproductive functions as a useful approach 
to the problem of aging.  Nonetheless, some are willing 
to trade-off some of their adaptive functions for an 
increased lifespan, and for them this “anti-aging” 
strategy will have its attractions. 
 
Finally, we have SENS [3].  Taking “Strategies for 
Engineering Negligible Senescence” literally as worded, 
it is impossible to object to, at least as a technological 
ambition.  The problems arise with the conceit that 
aging is due entirely to seven types of cellular or 
molecular damage.  For those well-trained in medical 
pathology, this assertion flies directly in the face of the 
remarkably diverse ways in which the aging human 
body manages to get things wrong as it becomes older.  
Aging involves derelictions of function at many 
different levels of biological organization, in strikingly 
heterogeneous ways across different types of tissue and 
organ, as a reasonable reading of the aging literature, 
medical or comparative, would show an open-minded 
reader [vid. 23].  And this is just as evolutionary 
biologists have long expected. 
 
Aging is not due to the progressive breakdown of a 
complex biochemical machine due to accretions of 
damage afflicting an entity that could otherwise 
continue functioning indefinitely.  The fact that it is 
well within the capacity of evolution by natural 
selection to produce organisms that don’t age shows 
that there is something wrong with this assumption.  
Instead, evolution by natural selection does not bother 
building ovigerous organisms that can live indefinitely, 
because the genomically-complex and information-
laden adaptations required for indefinite survival of 
such adult somata are not favored by natural selection.  
This results in the absence of the substantial amount of 
genomic information that is required to sustain life 
indefinitely.  It isn’t damaged information, any more 
than the aging body merely suffers damage during aging 
and nothing else.  The adaptive genomic information 
required for indefinite survival simply hasn’t been 
produced by evolution. 
 
Extending Healthspan requires Extending Adaptation 
 
To evolutionary biologists, then, the problem of 
extending healthspan is how to produce the adaptations 
required to sustain high levels of function at later ages.  
Evolutionary biologists have known since the 1950’s 
that lifespan can be increased fairly predictably by 
curtailing reproduction and its associated physiological 
costs and stresses.  Drugs, surgery, and diet can all have 
this effect.  But the problem of a true extension of “a 
full life,” or “healthspan,” is more difficult, because it is 
nothing less than building a new set of later-age 
adaptations. 
 
  This difficult problem becomes trivially easy for us to 
solve when we can control Hamilton’s [1, 4] forces of 
natural selection:  when we tune these forces up at later 
ages in genetically variable populations over a number 
of generations, increased healthspan or, to us 
evolutionary biologists, prolonged adaptation is the 
predictable result [2, 27]. 
 
It is organisms whose evolution we can’t control that 
pose a severe technological problem of aging for 
evolutionists.  Evidently, as both a practical and an 
ethical matter, we can’t control human evolution.  
Contemporary evolutionists think of this as an 
impractical and morally dubious project, contrary to the 
eugenicists of the early 20th Century. 
 
On the view of aging presented here, extending human 
healthspan requires that we find means by which we can 
emulate what natural selection has already given us at 
earlier ages:  a broad spectrum of adaptations that have 
been produced by millions of years of fine-tuning the 
vast amount of information stored in each mammalian 
genome.  This is such a daunting prospect that most 
evolutionary biologists, who generally understand the 
point that the evolution of aging is founded on a failure 
of adaptation, regard the slowing of human aging as an 
essentially intractable problem.  But at least some 
evolutionists who used to feel that way have now 
changed their minds. 
 
Evolutionary Strategies for Extending Human 
Adaptation to Later Ages 
 
Experimental evolution and genomics are the 
technologies that have changed the prospects for 
extending human adaptation to later ages, in the eyes of 
some evolutionary biologists at least.  I will explain 
how by following the historical progression by which 
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this possibility was conceived by evolutionary 
biologists. 
 
Experimental evolution is the technique that has best 
fostered the scientific evaluation of the evolutionary 
theories and mechanisms of aging [28].  Experimental 
evolution is an empirical approach based on setting up 
conditions in which replicated populations are allowed 
to evolve, using either de novo mutations [29] or 
standing genetic variation [30] as “fuel” for the 
evolutionary process, and focused selection pressures of 
some type as the “steering” for the evolutionary process 
[31].  Some of the first tests of the basic Hamiltonian 
evolutionary theory for aging were performed using 
experimental protocols in which the first age of 
reproduction was progressively postponed in outbred 
Drosophila populations over more than ten generations 
[32].  For the last 30 years, such evolution experiments 
have repeatedly corroborated the evolutionary theory of 
aging [28].  
 
But more importantly, for the present purpose, these 
experiments have produced a variety of experimentally 
evolved populations in which adaptation has been 
sustained well on to later ages.  That is, organisms with 
slowed aging have been derived from organisms with a 
faster rate of aging; to use the language of adaptational 
biology, we have been able to extend the period of 
adequate adaptation from early life to later life.  
Comparing the extended-adaptation Drosophila with 
their matched controls has allowed useful physiological 
and genetic analysis of the mechanistic basis of 
extending adaptation [27].  In particular, it was soon 
estimated that many genes were involved in this 
prolongation of Drosophila adaptation, implicating a 
large amount of genomic change in the re-tuning of the 
aging process [10]. 
 
In the 1980s, evolutionary biologists did not think 
longer-lived Drosophila would provide much, if any, 
useful guide to the specific genomic foundations of 
aging in humans, because of then-prevailing 
expectations among evolutionary biologists that there 
would be wide divergence of genomes among phylo-
genetically distant species [vid. 33].  [In this respect, the 
prejudices of many molecular biologists were more 
accurate than those of mainstream evolutionary 
biologists before the advent of genomics.]  Thus it was 
proposed that progress in finding the right genomic and 
physiological information for postponing human aging 
required the development of mice with selectively 
postponed aging [34].  Unfortunately, while it was 
shown that the same evolutionary methods as those used 
with Drosophila also worked in a small-scale mouse 
experiment [35], the level of replication used in that 
experiment was not sufficient to make these mice 
promising material for genetic or physiological analysis.  
Despite repeated attempts to produce a consensus that 
the creation of properly replicated populations of mice 
with evolutionarily extended adaptation would benefit 
gerontological research, the project was never attempted 
[36].  This seemed to preclude any reasonable prospect 
for evolutionary biology contributing to the 
amelioration of human aging. 
 
The advent of whole-genome technologies, or 
“genomics,” circa the year 2000 changed the situation 
substantially.  Most importantly, it was realized that there 
was far more orthology among the genes of metazoan 
genomes than had been anticipated by evolutionary 
biologists, particularly within the segmented bilaterian 
group, which includes both insects and mammals.  
Genome-wide studies comparing the loci involved in 
Drosophila aging with the entire human genome give 
estimates of orthology that are quite high, well over 80% 
[37], suggesting the possibility of extrapolating from 
Drosophila evolutionary genomics to humans in the case 
of aging.  This may be because the many loci which must 
evolve in order to sustain adaptation at later ages are 
involved in common “housekeeping” functions, such as 
energetic metabolism – which has been extensively 
implicated in the evolution of slowed aging in fruit flies 
[27], rather than lineage-specific loci, in most cases.  This 
in turn leads to the possibility of developing 
pharmaceutical and other interventions for human aging 
based on research that starts with the genomic 
information required to sustain adaptation, and thus 
health, in older fruit flies [36-39].   
 
Naturally, any such genomic short-cut to reverse-
engineering the evolution of slowed aging from fruit flies 
to humans is fraught with potential for error.  Such 
evolutionarily deep orthologies are sure to supply 
incomplete information.  The originally proposed 
evolutionarily  slowed-aging mouse remains the best 
model organism for a project of this kind.  But creating it 
will be a demanding project, requiring years to produce 
fruitful results, and substantial resources [34, 39].  For the 
time being, the most feasible evolutionary strategy for 
extending human adaptation into later years is that based 
on experimental evolution with model organisms like 
Drosophila, particularly because such organisms already 
exist and the physiological changes associated with their 
slowed aging have already been studied extensively. 
 
Conclusion: Bridging the Two Cultures of Aging 
Research 
 
This review evidently proposes that both the scientific 
foundations of gerontology and the systematic, rather 
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than adventitious, slowing of human aging would 
benefit from the use of evolutionary theory and 
experimental evolution augmented with genomics.  This 
is because aging is properly understood as the fading 
out of adaptation with adult age.  As evolutionary 
biologists have been studying adaptation for 150 years, 
and because we have an extensive tool kit for such 
research [40], we evolutionists naturally think that 
progress in gerontological research would be materially 
accelerated by the use of evolutionary foundations and 
tools [2, 41].  This doesn’t mean gerontologists 
becoming evolutionary biologists, anymore than human 
geneticists are all population geneticists.  But it does 
mean bridging the gaps between gerontology and 
evolutionary biology, just as human geneticists talk and 
collaborate with population geneticists. 
 
Nor should this be construed as an argument that 
gerontology can do without any of the skills that are 
deployed so resourcefully by mainstream geronto-
logists.  Evolutionary biologists have a long history, 
indeed as old as Charles Darwin’s original publications, 
of making use of all elements of biology, both as 
sources of information and as sources of useful tools for 
their own experiments.  Evolutionary research on aging 
has been no exception to this overall pattern.  
  
But evolutionists are generally united in their 
impatience with gerontological theories that are 
incompatible with evolutionary theory.  And we chiefly 
feel scorn toward “anti-aging medicine” that is based on 
presumptions precisely contrary to evolutionary 
biology, just as we feel toward creationism.  We offer 
the formal foundation necessary for mathematically 
sorting out much gerontological theorizing. We can 
supply useful experimental strategies from our 
longstanding tradition of studying adaptation, and we 
can demonstrably produce model organisms with 
extended healthspan at will.  We feel that gerontology 
can prosper if it makes use of these substantive 
contributions. 
 
I hope that I have managed to explain to a few more 
gerontologists why they should make material use of 
evolutionary thinking in their theoretical and 
experimental research.  It provides concrete founda-
tions, not window dressings. 
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